Leishmaniasis: A new method for confirming cure and detecting asymptomatic infection in patients receiving immunosuppressive treatment for autoimmune disease.
Visceral leishmaniasis (VL) in patients receiving immunosuppressant drugs for autoimmune disease has been on the rise. It is important-but difficult-to know when cure has been achieved in these patients since the withdrawal of immunosuppressants during antileishmania treatment is commonly required,...
Guardado en:
Autores principales: | Laura Botana, Ana Victoria Ibarra-Meneses, Carmen Sanchez, Belen Matia, Juan Victor San Martin, Javier Moreno, Eugenia Carrillo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/79b394a01ce3498fa073f55eb5423ef2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Predictive models for the diagnostic of human visceral leishmaniasis in Brazil.
por: Tália S Machado de Assis, et al.
Publicado: (2012) -
Control of visceral leishmaniasis in latin america-a systematic review.
por: Gustavo A S Romero, et al.
Publicado: (2010) -
Agrochemicals against malaria, sleeping sickness, leishmaniasis and Chagas disease.
por: Matthias Witschel, et al.
Publicado: (2012) -
Early clinical manifestations associated with death from visceral leishmaniasis.
por: Valdelaine Etelvina Miranda de Araújo, et al.
Publicado: (2012) -
Human leishmaniasis vaccines: Use cases, target population and potential global demand.
por: Stefano Malvolti, et al.
Publicado: (2021)